Viewing Study NCT03266757


Ignite Creation Date: 2025-12-24 @ 6:40 PM
Ignite Modification Date: 2026-01-04 @ 8:16 AM
Study NCT ID: NCT03266757
Status: COMPLETED
Last Update Posted: 2019-04-05
First Post: 2017-07-18
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Borderline Resectable or Resectable or Advanced Pancreatic Adenocarcinoma
Sponsor: Hellenic Society of Medical Oncology
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Outcomes Module Eligibility Module